สำนักงานคณะกรรมการกำกับหลักทรัพย์และตลาดหลักทรัพย์

Printed on 06 December 2025 13:40

Publication Document

Please enter search criteria
Document Type
Issuer / Underlying / Securities
Date From
To

M.D.X. PUBLIC COMPANY LIMITED : MDX

The Financial Statements which need to be revised ( 0 record(s) found)
Order DateCompany NameReviewed Financial Statement Details
Data not found
Finanacial Statements ( 220 record(s) found)
NameYearStatusTypePeriodAs OfDetails
M.D.X. PUBLIC COMPANY LIMITED2025ReviewedConsolidatedQ330/09/2025
M.D.X. PUBLIC COMPANY LIMITED2025ReviewedCompanyQ330/09/2025
M.D.X. PUBLIC COMPANY LIMITED2025ReviewedCompanyQ230/06/2025
M.D.X. PUBLIC COMPANY LIMITED2025ReviewedConsolidatedQ230/06/2025
M.D.X. PUBLIC COMPANY LIMITED2025ReviewedConsolidatedQ131/03/2025
M.D.X. PUBLIC COMPANY LIMITED2025ReviewedCompanyQ131/03/2025
M.D.X. PUBLIC COMPANY LIMITED2024AuditedCompanyYear31/12/2024
M.D.X. PUBLIC COMPANY LIMITED2024AuditedConsolidatedYear31/12/2024
M.D.X. PUBLIC COMPANY LIMITED2024ReviewedConsolidatedQ330/09/2024
M.D.X. PUBLIC COMPANY LIMITED2024ReviewedCompanyQ330/09/2024
Key Financial Ratio ( 0 record(s) found)
NameBusiness TypeTypePeriodYearAs OfDetails
Data not found
Management's Discussion and Analysis ( 12 record(s) found)
DateTimeHeadingLink
13/11/202517:15Management Discussion and Analysis Quarter 3 Ending 30 Sep 2025
14/08/202518:26Management Discussion and Analysis Quarter 2 Ending 30 Jun 2025
15/05/202512:45Management Discussion and Analysis Quarter 1 Ending 31 Mar 2025
28/02/202519:16Management Discussion and Analysis Yearly Ending 31 Dec 2024
14/11/202418:59Management Discussion and Analysis Quarter 3 Ending 30 Sep 2024 (Revised)
14/08/202417:25Management Discussion and Analysis Quarter 2 Ending 30 Jun 2024
15/05/202420:37Management Discussion and Analysis Quarter 1 Ending 31 Mar 2024
28/02/202421:44Management Discussion and Analysis Yearly Ending 31 Dec 2023 (Revised)
14/11/202317:53Management Discussion and Analysis Quarter 3 Ending 30 Sep 2023
16/08/202319:02Management Discussion and Analysis Quarter 2 Ending 30 Jun 2023
SEC has ordered to amend Finanacial Statements ( 0 record(s) found)
NameDescriptionDetails
Data not found

Last updated on 05 December 2025